京天成生物

京天成生物

京天成生物

Biotech/Healthcare

Jingtiancheng Biotechnology develops monoclonal antibody detection reagents. It operates platforms for antibody development and diagnostic kit development and has created tens of thousands of mouse monoclonal antibodies and rabbit and monkey polyclonal antibodies, as well as hundreds of detection…

Latest round: Series B (2025)

Source: ChinaBulls — chinabulls.com

Last updated 2025-04-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.